ROIV insider trades & Congress trades
Roivant Sciences Ltd.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 21 open-market insider transactions in Roivant Sciences Ltd. (ROIV) (0 purchases with code P and 21 sales with code S), the most recent on November 3, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 21 sales by 4 ($74.4M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Venker Eric | President & Immunovant CEO | Sell | 200,000 | $36.31 | $7.26M | – |
| Oct 28, 2026 | Venker Eric | President & Immunovant CEO | Sell | 200,000 | $36.59 | $7.32M | – |
| Oct 20, 2026 | Venker Eric | President & Immunovant CEO | Sell | 185,856 | $35.09 | $6.52M | – |
| Oct 20, 2026 | Venker Eric | President & Immunovant CEO | Sell | 14,144 | $35.42 | $501K | – |
| Oct 1, 2026 | Epperly Melissa B, | Chief Financial Officer | Sell | 16,850 | $36.08 | $608K | – |
| Oct 1, 2026 | Epperly Melissa B, | Chief Financial Officer | Sell | 900 | $36.57 | $33K | – |
| Sep 30, 2026 | Venker Eric | President & Immunovant CEO | Sell | 200,000 | $36.62 | $7.32M | +0.0% |
| Sep 15, 2026 | Fitzgerald Meghan | – | Sell | 4,712 | $39.68 | $187K | −0.2% |
| Sep 15, 2026 | Fitzgerald Meghan | – | Sell | 400 | $40.45 | $16K | −0.2% |
| Sep 15, 2026 | Epperly Melissa B, | Chief Financial Officer | Sell | 4,338 | $39.65 | $172K | −0.2% |
| Sep 15, 2026 | Epperly Melissa B, | Chief Financial Officer | Sell | 600 | $40.38 | $24K | −0.2% |
| Sep 8, 2026 | Fitzgerald Meghan | – | Sell | 20,000 | $39.90 | $798K | −0.1% |
| Aug 28, 2026 | Venker Eric | President & Immunovant CEO | Sell | 166,182 | $35.63 | $5.92M | +0.0% |
| Aug 28, 2026 | Venker Eric | President & Immunovant CEO | Sell | 33,818 | $36.44 | $1.23M | +0.0% |
| Aug 21, 2026 | Sukhatme Mayukh | President & CIO | Sell | 144,756 | $36.48 | $5.28M | +0.1% |
| Aug 20, 2026 | Sukhatme Mayukh | President & CIO | Sell | 17,519 | $37.30 | $653K | +0.1% |
| Aug 19, 2026 | Sukhatme Mayukh | President & CIO | Sell | 172,899 | $37.17 | $6.43M | +0.1% |
| Aug 18, 2026 | Sukhatme Mayukh | President & CIO | Sell | 105,141 | $36.59 | $3.85M | +0.1% |
| Aug 18, 2026 | Sukhatme Mayukh | President & CIO | Sell | 31,801 | $37.18 | $1.18M | +0.1% |
| Aug 17, 2026 | Sukhatme Mayukh | President & CIO | Sell | 284,707 | $36.25 | $10.3M | +0.1% |
| Aug 14, 2026 | Sukhatme Mayukh | President & CIO | Sell | 243,177 | $36.23 | $8.81M | +0.1% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.